Table 2 Hemoglobin concentration, blood... | American Society of Hematology

Table 2

Hemoglobin concentration, blood cell counts, mean platelet volume, and serum TPO level of patients with ANKRD26 mutations

Parameter (no. of investigated patients)	Patients, mean (SD), no. of cases with values higher/lower than the normal range	Healthy subjects, mean (normal range)	One sample t test vs mean value of healthy subjects, P (P vs upper/lower reference limit)
Hemoglobin, g/dL
Male (n = 40)	15.4 (1.9), 4/7	15.7 (14.0-17.5)*	.32
Female (n = 38)	13.5 (1.4), 5/4	13.8 (12.3-15.3)*	.19
WBC, × 10⁹/L (n = 78)	9.2 (2.8), 14/2	7.8 (4.4-11.3)*	< .001 (1.000)†
Neutrophils, × 10⁹/L (n = 78)	5.51 (2.3), 11/3	4.4 (1.8-7.7)*	< .001 (1.000)†
Platelets, × 10⁹/L (n = 78)	47.5 (28.3), 0/77	307 (150-400)*	< .001 (< .001)‡
MPV, fL (n = 71)	9.3 (1.6), 1/15	10.7 (8.0-13.4)*	< .001 (1.000)†
TPO, pg/mL (n = 38)	112.9 (62.5), 29/0	14.6 (6.9-54.4)§	< .001 (< .001)†

Parameter (no. of investigated patients)	Patients, mean (SD), no. of cases with values higher/lower than the normal range	Healthy subjects, mean (normal range)	One sample t test vs mean value of healthy subjects, P (P vs upper/lower reference limit)
Hemoglobin, g/dL
Male (n = 40)	15.4 (1.9), 4/7	15.7 (14.0-17.5)*	.32
Female (n = 38)	13.5 (1.4), 5/4	13.8 (12.3-15.3)*	.19
WBC, × 10⁹/L (n = 78)	9.2 (2.8), 14/2	7.8 (4.4-11.3)*	< .001 (1.000)†
Neutrophils, × 10⁹/L (n = 78)	5.51 (2.3), 11/3	4.4 (1.8-7.7)*	< .001 (1.000)†
Platelets, × 10⁹/L (n = 78)	47.5 (28.3), 0/77	307 (150-400)*	< .001 (< .001)‡
MPV, fL (n = 71)	9.3 (1.6), 1/15	10.7 (8.0-13.4)*	< .001 (1.000)†
TPO, pg/mL (n = 38)	112.9 (62.5), 29/0	14.6 (6.9-54.4)§	< .001 (< .001)†

WBC indicates white blood cells; and MPV, mean platelet volume.

Reference values of hospital central laboratory.

Versus upper reference limit.

Versus lower reference limit.

Values obtained in 50 healthy subjects.